| 000 | 00826 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513173444.0 | ||
| 264 | 0 | _c19961022 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a1170-7690 | ||
| 024 | 7 |
_a10.2165/00019053-199600093-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Damme, P | |
| 245 | 0 | 0 |
_aEconomic evaluation of vaccination. _h[electronic resource] |
| 260 |
_bPharmacoEconomics _c1996 |
||
| 300 |
_a8-15; discussion 23-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aVaccination _xeconomics |
| 700 | 1 | _aBeutels, P | |
| 773 | 0 |
_tPharmacoEconomics _gvol. 9 Suppl 3 _gp. 8-15; discussion 23-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00019053-199600093-00005 _zAvailable from publisher's website |
| 999 |
_c10119987 _d10119987 |
||